tiprankstipranks
Trending News
More News >
Prothena (DE:0PT)
FRANKFURT:0PT

Compare Prothena (0PT) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Prothena
€7.35
€407.65M
-5.95
-37.18%
3 Buy
1 Hold
1 Sell
Moderate Buy
Lexicon Pharmaceuticals
$1.56
$660.94M
-8.29
353.49%
3 Buy
1 Hold
0 Sell
Strong Buy
XOMA Royalty Corporation
$28.71
$341.81M
15.08
36.32%
2 Buy
1 Hold
0 Sell
Moderate Buy
Zevra Therapeutics
$9.23
$541.91M
5.95
15.23%
8 Buy
0 Hold
0 Sell
Strong Buy
Corvus Pharmaceuticals
$13.33
$1.12B
-39.78
216.63%
5 Buy
0 Hold
0 Sell
Strong Buy
Alumis Inc.
$25.06
$3.09B
-34.11
601.96%
9 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:0PT
Prothena
7.35
-4.55
-38.24%
LXRX
Lexicon Pharmaceuticals
1.56
1.20
333.33%
XOMA
XOMA Royalty Corporation
28.71
7.78
37.17%
ZVRA
Zevra Therapeutics
9.23
1.02
12.42%
CRVS
Corvus Pharmaceuticals
13.33
9.08
213.65%
ALMS
Alumis Inc.
25.06
21.29
563.84%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts